News & Press Releases

Mintz has added sought-after private equity dealmaker Griffin Doty as a Member in its New York office, further advancing the firm’s strategic growth and investment in its corporate practice in a highly competitive market. Griffin is a recognized presence in private equity circles, and known for his creative problem-solving on complex, high-stakes transactions. He joins from McDermott Will & Schulte.

Mintz advised the underwriters in connection with Avalo Therapeutics’ $431.3 million public offering of common stock and pre-funded warrants.

Mintz advised the underwriters in connection with InflaRx’s $150 million underwritten offering of ordinary shares.

Mintz advised Axoft, a neurotechnology company, on a $55 million Series A financing round. The funding will be used to expand Axoft’s clinical trials globally and progress US regulatory approval for its implantable Brain-Computer Interfaces (iBCIs).  

Sige Gutman, Chair of Mintz’s Life Sciences Litigation Practice, was quoted in an Endpoints News article examining Supreme Court oral arguments on the limits of “skinny label” drug marketing and potential patent infringement liability for generic manufacturers.

Mintz advised Potentia Inc. (Potentia), a leading developer of large-scale technology and energy infrastructure, on the closing today of its investment in Heartland Industrial Park, a major technology infrastructure development located in Sullivan County, Indiana.